Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 3
2010 4
2011 2
2012 2
2013 2
2014 4
2015 4
2016 5
2017 13
2018 8
2019 11
2020 13
Text availability
Article attribute
Article type
Publication date

Search Results

68 results
Results by year
Filters applied: . Clear all
Page 1
LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling.
Luo J, Wang K, Yeh S, Sun Y, Liang L, Xiao Y, Xu W, Niu Y, Cheng L, Maity SN, Jiang R, Chang C. Luo J, et al. Among authors: xu w. Nat Commun. 2019 Jun 12;10(1):2571. doi: 10.1038/s41467-019-09784-9. Nat Commun. 2019. PMID: 31189930 Free PMC article.
Dual inhibition of AKT-mTOR and AR signaling by targeting HDAC3 in PTEN- or SPOP-mutated prostate cancer.
Yan Y, An J, Yang Y, Wu D, Bai Y, Cao W, Ma L, Chen J, Yu Z, He Y, Jin X, Pan Y, Ma T, Wang S, Hou X, Weroha SJ, Karnes RJ, Zhang J, Westendorf JJ, Wang L, Chen Y, Xu W, Zhu R, Wang D, Huang H. Yan Y, et al. Among authors: xu w. EMBO Mol Med. 2018 Apr;10(4):e8478. doi: 10.15252/emmm.201708478. EMBO Mol Med. 2018. PMID: 29523594 Free PMC article.
TMPRSS2-ERG Controls Luminal Epithelial Lineage and Antiandrogen Sensitivity in PTEN and TP53-Mutated Prostate Cancer.
Blee AM, He Y, Yang Y, Ye Z, Yan Y, Pan Y, Ma T, Dugdale J, Kuehn E, Kohli M, Jimenez R, Chen Y, Xu W, Wang L, Huang H. Blee AM, et al. Among authors: xu w. Clin Cancer Res. 2018 Sep 15;24(18):4551-4565. doi: 10.1158/1078-0432.CCR-18-0653. Epub 2018 May 29. Clin Cancer Res. 2018. PMID: 29844131 Free PMC article.
Retraction: miR-5089-5p suppresses castration-resistant prostate cancer resistance to enzalutamide and metastasis via miR-5089-5p/SPINK1/ MAPK/MMP9 signaling.
Wang ZC, Li Y, Wang KL, Wang L, You BS, Zhao DF, Liu ZQ, Fang RZ, Wang JQ, Zhang W, Zhang JM, Xu WH. Wang ZC, et al. Aging (Albany NY). 2020 Oct 31;12(20):20930. doi: 10.18632/aging.104212. Epub 2020 Oct 31. Aging (Albany NY). 2020. PMID: 33156816 Free PMC article. No abstract available.
EGR1 regulates angiogenic and osteoclastogenic factors in prostate cancer and promotes metastasis.
Li L, Ameri AH, Wang S, Jansson KH, Casey OM, Yang Q, Beshiri ML, Fang L, Lake RG, Agarwal S, Alilin AN, Xu W, Yin J, Kelly K. Li L, et al. Among authors: xu w. Oncogene. 2019 Aug;38(35):6241-6255. doi: 10.1038/s41388-019-0873-8. Epub 2019 Jul 16. Oncogene. 2019. PMID: 31312026 Free PMC article.
CD103-positive CSC exosome promotes EMT of clear cell renal cell carcinoma: role of remote MiR-19b-3p.
Wang L, Yang G, Zhao D, Wang J, Bai Y, Peng Q, Wang H, Fang R, Chen G, Wang Z, Wang K, Li G, Yang Y, Wang Z, Guo P, Peng L, Hou D, Xu W. Wang L, et al. Among authors: xu w. Mol Cancer. 2019 Apr 11;18(1):86. doi: 10.1186/s12943-019-0997-z. Mol Cancer. 2019. PMID: 30975145 Free PMC article.
The Coronavirus Transmissible Gastroenteritis Virus Evades the Type I Interferon Response through IRE1α-Mediated Manipulation of the MicroRNA miR-30a-5p/SOCS1/3 Axis.
Ma Y, Wang C, Xue M, Fu F, Zhang X, Li L, Yin L, Xu W, Feng L, Liu P. Ma Y, et al. Among authors: xu w. J Virol. 2018 Oct 29;92(22):e00728-18. doi: 10.1128/JVI.00728-18. Print 2018 Nov 15. J Virol. 2018. PMID: 30185587 Free PMC article.
Advances in the Development of Anticancer HSP-based Vaccines.
Baldin AV, Zamyatnin AA Jr, Bazhin AV, Xu WH, Savvateeva LV. Baldin AV, et al. Curr Med Chem. 2019;26(3):427-445. doi: 10.2174/0929867325666180129100015. Curr Med Chem. 2019. PMID: 29376489 Review.
MicroRNA-497 suppresses renal cell carcinoma by targeting VEGFR-2 in ACHN cells.
Pengcheng S, Ziqi W, Luyao Y, Xiangwei Z, Liang L, Yuwei L, Lechen L, Wanhai X. Pengcheng S, et al. Among authors: wanhai x. Biosci Rep. 2017 May 19;37(3):BSR20170270. doi: 10.1042/BSR20170270. Print 2017 Jun 30. Biosci Rep. 2017. PMID: 28465356 Free PMC article.
Biomarkers of Renal Tumors: the Current State and Clinical Perspectives.
Golovastova MO, Korolev DO, Tsoy LV, Varshavsky VA, Xu WH, Vinarov AZ, Zernii EY, Philippov PP, Zamyatnin AA Jr. Golovastova MO, et al. Curr Urol Rep. 2017 Jan;18(1):3. doi: 10.1007/s11934-017-0655-1. Curr Urol Rep. 2017. PMID: 28110463 Review.
68 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback